TITLE

Review: Antidepressants increase remission and clinical improvement in bulimia nervosa

AUTHOR(S)
Morgan, John F.
PUB. DATE
May 2002
SOURCE
ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p106
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments on a study which examined antidepressants versus placebo for people with bulimia nervosa. Effectiveness of antidepressants in patients with bulimia nervosa (BN); Treatment generally regarded as the treatment of choice for BN.
ACCESSION #
8856107

 

Related Articles

  • Review: Psychological treatment is as effective as antidepressants for bulimia nervosa, but a combination is best.  // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p107 

    Comments on a study which examined antidepressants versus psychologial treatments and their combination for bulimia nervosa. Effectiveness of psychological treatment (PT) and antidepressants in patients with bulimia nervosa; Benefits from a combination and antidepressants and PT than each...

  • Possible hepatotoxicity of zimelidine. Simpson, G.K.; Davidson, N. McD // British Medical Journal (Clinical Research Edition);10/22/1983, Vol. 287 Issue 6400, p1181 

    Reports a patient with hepatocellular jaundice and fever during treatment with zimelidine. Function of zimelidine in the neuronal system; Complains on depressive symptoms; Recommendation for monitoring and reporting of side effects of zimelidine.

  • Mianserin-induced agranulocystosis. Page, Charlotte // British Medical Journal (Clinical Research Edition);6/26/1982, Vol. 284 Issue 6333, p1912 

    Describes a case of agranulocytosis associated with the tetracyclic antidepressant mianserin administered to a 77-year-old woman in Great Britain. Improvement of the cognitive function; Complaint of chest pain after five weeks of treatment with mianserin; Effect of mianserin on the treatment...

  • Health advisories: when good intentions go bad. Mamdani, Muhammad M. // CMAJ: Canadian Medical Association Journal;4/8/2008, Vol. 178 Issue 8, p1025 

    A letter to the editor is presented in response to the article written by Laurence Katz and associates on the impact of Health Canada's warning on the rates of anti-depressant prescription that was published in the previous issue.

  • Antidepressants may not improve all symptoms of depression.  // Healthcare Counselling & Psychotherapy Journal;Jul2011, Vol. 11 Issue 3, p2 

    The article reports on research on depression which was conducted at the University of Texas Southwestern Medical Center and found that even people who have shown a positive treatment response to antidepressants continue to experience symptoms like insomnia, sadness and decreased concentration.

  • TALK THERAPY MAY BOLSTER EFFECTS OF ANTIDEPRESSANTS.  // Cleveland Clinic Men's Health Advisor;Feb2013, Vol. 15 Issue 2, p2 

    The article reports focuses on a study published in the December 6, 2012 issue of the journal "The Lancet" which shows that cognitive behavioral therapy (CBT) helps depressed patients to respond effectively to antidepressant medications.

  • Most cost effective antidepressant treatment in a Spanish setting?  // PharmacoEconomics & Outcomes News;9/18/2010, Issue 612, p8 

    The article discusses research on the cost effectiveness of escitalopram in treating patients with a major depressive disorder in Spain, which references the study "Do We Treat Different Patients With Different Antidepressant? Clinical and Economic Assessments in Spanish Setting," by M....

  • Antidepressants and upper gastrointestinal bleeding. Li Wan Po, Alain // BMJ: British Medical Journal (International Edition);10/23/99, Vol. 319 Issue 7217, p1081 

    Presents information on a study which investigated the increased risk of upper gastrointestinal bleeding associated with antidepressant therapy. Biochemical hypothesis on serotonin; How is clomipramine classified; Suggestions and conclusions.

  • Prozac Nation. Kalbhen, Janet // H&HN: Hospitals & Health Networks;Aug99, Vol. 73 Issue 8, p49 

    Focuses on Prozac and Zoloft, the depression-fighting pharmaceuticals used by Americans. Reason for the record setting hike in pharmacy benefit costs in 1998; Comment from Express Scripts, a pharmacy benefit manager.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics